Aibenyu Pharmaceutical: Flurbiprofen Gel Patch has obtained a drug registration certificate.

Kuifang Pharmaceutical announced that its controlling subsidiary, Kuifang Pharmaceutical Group Longzhong Co., Ltd., recently received the registration certificate for the ibuprofen gel patch issued by the National Medical Products Administration. The main ingredient of this medicine is ibuprofen, with a specification of 40mg of ibuprofen per patch. It is classified as a chemical medicine of Class 4, with the drug approval number being National Drug Approval H20264670. Indications include pain relief and anti-inflammatory effects for diseases such as osteoarthritis, adhesive capsulitis, tendinitis, and tenosynovitis. This approval will help the company enter the field of pain management and enrich the pipeline of pain patch products.